Antibodies to osteogenic proteins
AssigneeStryker Corporation
InventorsHermann Oppermann, Engin Ozkaynak, Thangavel Kuberasampath, David C. Rueger
Life of this patent
Estimating the term…
Loading patent…
AssigneeStryker Corporation
InventorsHermann Oppermann, Engin Ozkaynak, Thangavel Kuberasampath, David C. Rueger
Estimating the term…
Disclosed are (1) osteogenic devices comprising a matrix containing substantially pure natural-sourced mammalian osteogenic protein; (2) DNA and amino acid sequences for novel polypeptide chains useful as subunits of dimeric osteogenic proteins; (3) vectors carrying sequences encoding these novel polypeptide chains and host cells transfected with these vectors; (4) methods of producing these polypeptide chains using recombinant DNA technology; (5) antibodies specific for these novel polypeptide chains; (6) osteogenic devices comprising these recombinantly produced proteins in association with an appropriate carrier matrix; and (7) methods of using the osteogenic devices to mimic the natural course of endochondral bone formation in mammals.
An isolated antibody having binding specificity for an epitope on a protein comprising an amino acid sequence selected from the group consisting of:
An isolated antibody having binding specificity for a protein comprising an amino acid sequence selected from the group consisting of:
An isolated antibody having binding specificity for a protein comprising an amino acid sequence selected from the group consisting of:
An isolated antibody having binding specificity for a protein comprising an amino acid sequence selected from the group consisting of:
An isolated antibody having binding specificity for an epitope on a protein comprising an amino acid sequence selected from the group consisting of:
Dependencies are inferred from the claim text.